When was Model Medicines founded?

Model Medicines was founded in 2019 and raised its 1st funding round 1 year after it was founded.

Where is Model Medicines located?

Model Medicines is headquartered in San Diego, United States.

How many employees does Model Medicines have?

As of Jun 30, 2026, the latest employee count at Model Medicines is 15.

Is Model Medicines a funded company?

Model Medicines is a funded company, having raised a total of $27.1M across 6 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on Aug 12, 2020.

When was the latest funding round of Model Medicines?

Model Medicines' latest funding was a $***** Series A round on Oct 29, 2025, with participation from 0 investor. Its primary sector is Life Sciences Tech. In United States, the Life Sciences Tech sector has seen $3.34B in funding in 2026 to date.

Where does Model Medicines rank among its competitors?

Model Medicines ranks 28th amongst 213 active competitors, of which 71 are funded. It stands 11th in terms of total funding among its competitors. The most recent competitor to raise funding was Isomorphic Labs, which secured $2.1B in May, 2026.

Who are the top competitors of Model Medicines?

Model Medicines' top competitors include Schrodinger, Recursion Pharmaceuticals and Valo Health. Among them, Isomorphic Labs secured the most recent funding round in May, 2026.

Model Medicines - 2026 Company Profile, Team, Funding & Competitors

Model Medicines is a series A company based in San Diego (United States), founded in 2019 by Daniel Haders and Sean Russell. It operates as a Developer of AI-based drug discovery platform. Model Medicines has raised $27.1M in funding from investors like Irving Investors, 8VC and Nex Cubed. The company has 213 active competitors, including 71 funded and 13 that have exited. Its top competitors include companies like Schrodinger, Recursion Pharmaceuticals and Valo Health.

Company Details

Developer of AI-based drug discovery platform. The company focuses on therapeutics for gastric disorders, neurological disorders, weight disorders, and infectious diseases. Also, uses the collection of drug development data, a drug and disease agnostic discovery platform along with AI to develop drugs.

Website: modelmedicines.com
Social
Email ID: *****@modelmedicines.com

Key Metrics

Founded Year

2019

Location

San Diego, United States

Stage

Series A

Total Funding

$27.1M in 6 rounds

Latest Funding Round

Series A, Oct 29, 2025, $*****

Investors

Irving Investors & 4 more

Ranked

28^th among 213 active competitors

Employee Count

15 as on Jun 30, 2026

Similar Companies

OpenEvidence & 2725 more

View Model Medicines' full profile

Model Medicines has raised a total funding of $27.1M over 6 rounds. Its first funding round was on Aug 12, 2020. Model Medicines has 5 institutional investors.

Here is the list of recent funding rounds of Model Medicines:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 29, 2025	5275193	Series A	6686385	3454507	2056658	5698731
Sep 26, 2024	6427035	Series A	6344270	3354006	4200851	2539684
Dec 21, 2023	4902892	Series A	7401819	3080274	4209777	4774290

Access funding benchmarks and valuations. Sign up today!

View details of Model Medicines's funding rounds and investors

The founders of Model Medicines are Daniel Haders and Sean Russell.

Here are the details of Model Medicines' key team members:

Daniel Haders: Co-Founder, Board Director, Executive Chairman of Model Medicines.
Sean Russell: Co-Founder, Chief Operating Officer & Head of Discovery, Research & Development of Model Medicines.

View details of Model Medicines's Founder profiles and Board Members

Model Medicines' employee count trend

Model Medicines has 15 employees as of Jun 26. Here is Model Medicines's employee count trend over the years:

Employee count trend for Model Medicines

Uncover Model Medicines' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Model Medicines include Schrodinger, Recursion Pharmaceuticals and Valo Health. Here is the list of Top 10 competitors of Model Medicines, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Schrodinger 1990, New York City (United States), Acquired	Provider of a web-based simulation and modelling tool	$162M	Gates, WuXi AppTec & 16 others	74/100
2nd	Recursion Pharmaceuticals 2013, New York (United States), Public	AI-enabled drug discovery and development platform for novel therapeutics	$452M	Baillie Gifford, DCVC & 47 others	72/100
3rd	Valo Health 2019, Boston (United States), Series B	AI-powered platform for drug discovery and development	$450M	PSP Investments, Koch Disruptive Technologies ... & 7 others	67/100
4th	XtalPi 2014, Cambridge (United States), Public	AI-based drug research and development company	$785M	SoftBank Vision Fund, Orbimed & 25 others	67/100
5th	Isomorphic Labs 2021, London (United Kingdom), Series B	Digital platform focused on revolutionizing drug discovery using AI	$2.7B	Thrive Capital, CapitalG & 6 others	64/100
6th	Xaira 2023, San Francisco (United States), Series D	AI-enabled platform for drug discovery and development	$1B	Arch Venture Partners, Foresite Labs & 11 others	63/100
7th	In Silico 2014, Cambridge (United States), Public	AI-enabled bioinformatics platform for drug discovery and biomarker development	$510M	Qiming Venture Partners, Prosperity7 Ventures ... & 36 others	62/100
8th	Tandem AI 2021, New York (United States), Series A	AI-based drug discovery tool for researchers	$82M	Orbimed, Chengwei Capital & 4 others	62/100
9th	Causaly 2018, London (United Kingdom), Series B	Provider of an AI platform for life sciences and biomedical research	$93M	Index Ventures, EBRD & 14 others	62/100
10th	Aqemia 2019, Paris (France), Series A	Provider of an AI and quantum physics to discover therapeutic molecules	$101M	Cathay Innovation, Elaia & 4 others	62/100
28th	Model Medicines 2019, San Diego (United States), Series A	Developer of AI-based drug discovery platform	$27.1M	Irving Investors, 8VC & 3 others	53/100